Skip to Content

M T13 (Topiramate 100 mg)

Pill with imprint M T13 is White, Round and has been identified as Topiramate 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M T13

Topiramate

Imprint
M T13
Strength
100 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-6103 Mylan Pharmaceuticals Inc.
51079-0728 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M T13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.